Literature DB >> 27113333

Office-based biopsies for laryngeal lesions: Analysis of consecutive 581 cases.

Wonjae Cha1,2, Byung-Woo Yoon3, Jeon Yeob Jang3, Jin Choon Lee4,5, Byung Joo Lee3,4, Soo-Geun Wang3,4, Jae Keun Cho6, Ilyoung Cho3.   

Abstract

OBJECTIVES/HYPOTHESIS: Office-based biopsy (OBB) is widely used to diagnose suspicious laryngeal lesions. However, its routine use is still controversial and the algorithm for clinical strategy is not concrete. We tried to evaluate the accuracy of OBB as a diagnostic tool for laryngeal malignancy.
METHODS: Medical data of 581 patients undergoing OBB were reviewed. Diagnostic values of OBB were analyzed for malignancy and malignancy/premalignancy. False negative rates (FNRs) were analyzed according to subsites, lesion sizes, and morphology.
RESULTS: The collection rate of adequate specimens was 99.1%, and there were no complications during OBB. The false omission rates for malignancy of benign lesion; mild, moderate, and severe dysplasia; and carcinoma in situ (CIS) were 5.1%, 11.9%, 14.3%, 50.0%, and 100.0%, respectively. Sensitivity, specificity, positive predictive value, and negative predictive value for malignancy in OBB were 78.2%, 100.0%, 100.0%, and 87.3%, respectively. Those for malignancy/premalignancy in OBB were 88.2%, 86.7%, 85.7%, and 89.1%, respectively. The high FNRs were reported in glottis lesions (27.0%) and small lesions below 1 cm (27.5%). Morphologically fungating lesions showed low FNR (9.1%) compared to nonfungating ones.
CONCLUSION: Office-based biopsy could be used as an initial diagnostic tool for laryngeal malignancy for early detection and avoidance of general anesthesia. However, operative re-biopsy should be considered when severe dysplasia or CIS were reported in OBB, or when the lesions are clinically suspicious for malignancy. LEVEL OF EVIDENCE: 4. Laryngoscope, 126:2513-2519, 2016.
© 2016 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Office-based biopsy; diagnostic accuracy; endoscopic; larynx; malignancy

Mesh:

Year:  2016        PMID: 27113333     DOI: 10.1002/lary.25930

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  4 in total

1.  Impact of optimizing diagnostic workup and reducing the time to treatment in head and neck cancer.

Authors:  Henrieke W Schutte; Guido B van den Broek; Stefan C A Steens; Rosella P M G Hermens; Jimmie Honings; Henri A M Marres; Matthias A W Merkx; Willem L J Weijs; Anne I J Arens; Adriana C H van Engen-van Grunsven; Carla M L van Herpen; Johannes H A M Kaanders; Frank J A van den Hoogen; Robert P Takes
Journal:  Cancer       Date:  2020-07-07       Impact factor: 6.860

2.  Safety of esophagogastroduodenoscopy-guided forceps biopsy and the feasibility of esophagogastroduodenoscopy for evaluation of hypopharyngeal cancer.

Authors:  Hyun Jun Hong; Seok-Hoo Jeong; Won Shik Kim; Yu Jin Kim
Journal:  BMC Surg       Date:  2019-08-08       Impact factor: 2.102

3.  Office-Based Laryngeal Biopsy in Patients Ineligible for General Anesthesia.

Authors:  Francesco Mozzanica; Francesco Ottaviani; Daniela Ginocchio; Antonio Schindler
Journal:  Iran J Otorhinolaryngol       Date:  2020-11

4.  Diagnostic accuracy outcomes of office-based (outpatient) biopsies in patients with laryngopharyngeal lesions: A systematic review.

Authors:  Mervyn Owusu-Ayim; Sushil R Ranjan; Alison E Lim; Alexander D G Rogers; Jenny Montgomery; Susanne Flach; Jaiganaesh Manickavasagam
Journal:  Clin Otolaryngol       Date:  2022-01-17       Impact factor: 2.729

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.